These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23792409)

  • 21. Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes.
    Buzzetti R; Spoletini M; Zampetti S; Campagna G; Marandola L; Panimolle F; Dotta F; Tiberti C;
    Diabetes Care; 2015 Mar; 38(3):513-20. PubMed ID: 25567348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Itoh Y; Hanafusa T
    J Diabetes Investig; 2021 Apr; 12(4):510-515. PubMed ID: 32696593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, biochemical, and immunological characteristics of newly diagnosed nonobese diabetic patients aged 18-45 years in China.
    Zhang S; Sun Q; Feng K; Fu Y; Wang O; Ping F; Li Y
    J Diabetes Complications; 2012; 26(1):40-3. PubMed ID: 22226483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.
    Huang G; Xiang Y; Pan L; Li X; Luo S; Zhou Z
    Diabetes Metab Res Rev; 2013 Jul; 29(5):363-8. PubMed ID: 23390067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity.
    Moriguchi M; Noso S; Kawabata Y; Yamauchi T; Harada T; Komaki K; Babaya N; Hiromine Y; Ito H; Yamagata S; Murata K; Higashimoto T; Park C; Yamamoto A; Ohno Y; Ikegami H
    Metabolism; 2011 Jun; 60(6):761-6. PubMed ID: 20825955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.
    Falorni A; Calcinaro F
    Ann N Y Acad Sci; 2002 Apr; 958():99-106. PubMed ID: 12021088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes.
    Sabbah E; Savola K; Ebeling T; Kulmala P; Vähäsalo P; Ilonen J; Salmela PI; Knip M
    Diabetes Care; 2000 Sep; 23(9):1326-32. PubMed ID: 10977027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
    Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
    Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Islet Autoantibodies in Type 1 Diabetes.
    Kawasaki E
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
    Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
    Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.
    Genovese S; Bazzigaluppi E; Gonçalves D; Ciucci A; Cavallo MG; Purrello F; Anello M; Rotella CM; Bardini G; Vaccaro O; Riccardi G; Travaglini P; Morenghi E; Bosi E; Pozzilli P
    Eur J Endocrinol; 2006 Mar; 154(3):441-7. PubMed ID: 16498058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level.
    Urbanová J; Rypáčková B; Procházková Z; Kučera P; Cerná M; Anděl M; Heneberg P
    Diabet Med; 2014 Apr; 31(4):466-71. PubMed ID: 24102923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
    PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes.
    Nieto J; Castillo B; Astudillo M; Tosur M; Balasubramanyam A; Pietropaolo M; Redondo MJ
    Pediatr Diabetes; 2021 Sep; 22(6):882-888. PubMed ID: 34018301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?
    Tiberti C; Buzzetti R; Anastasi E; Dotta F; Vasta M; Petrone A; Cervoni M; Torresi P; Vecci E; Multari G; Di Mario U
    Diabetes Metab Res Rev; 2000; 16(1):8-14. PubMed ID: 10707033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.